BenzingaMar 12, 9:01 AM ETNeutral
As the parent company of Lucid Diagnostics, PAVmed is mentioned only in a corporate structure context. The announcement provides no direct information about PAVmed's operations or performance.
PAVmed news
$3.82+0.53%
Close Sep 29, 2026 · split-adjustedArticles · 30 days0English, de-duplicated
Positive0
Neutral0
Negative0
About PAVmed
No recent articles focused on PAVmed.
Also mentions PAVM
Articles that tag PAVM but are mainly about other companies.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology